Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 Imatinib Mesylate
3. Altmetric Badge
   Chapter 2 Dasatinib
4. Altmetric Badge
   Chapter 3 Nilotinib
5. Altmetric Badge
   Chapter 4 Bosutinib: a novel second-generation tyrosine kinase inhibitor.
6. Altmetric Badge
   Chapter 5 Ponatinib: A Third-Generation Inhibitor for the Treatment of CML.
7. Altmetric Badge
   Chapter 6 Erlotinib
8. Altmetric Badge
   Chapter 7 Lapatinib
9. Altmetric Badge
   Chapter 8 Sorafenib: targeting multiple tyrosine kinases in cancer.
10. Altmetric Badge
    Chapter 9 Sunitinib in the Treatment of Advanced Solid Tumors
11. Altmetric Badge
    Chapter 10 Regorafenib
12. Altmetric Badge
    Chapter 11 Crizotinib
13. Altmetric Badge
    Chapter 12 Cabozantinib: A MET, RET, and VEGFR2 Tyrosine Kinase Inhibitor
14. Altmetric Badge
    Chapter 13 Vemurafenib
15. Altmetric Badge
    Chapter 14 Dabrafenib
16. Altmetric Badge
    Chapter 15 Trametinib
17. Altmetric Badge
    Chapter 16 Ruxolitinib
18. Altmetric Badge
    Chapter 17 Ibrutinib
19. Altmetric Badge
    Chapter 18 Decitabine
20. Altmetric Badge
    Chapter 19 5-Azacytidine/5-Azacitidine
21. Altmetric Badge
    Chapter 20 Bortezomib
22. Altmetric Badge
    Chapter 21 Lenalidomide
23. Altmetric Badge
    Chapter 22 Pomalidomide
24. Altmetric Badge
    Chapter 23 Everolimus
25. Altmetric Badge
    Chapter 24 Temsirolimus
26. Altmetric Badge
    Chapter 25 Vismodegib